Navigation Links
Many Rheumatoid Arthritis Patients May Skip Meds: Study
Date:9/3/2014

WEDNESDAY, Sept. 3, 2014 (HealthDay News) -- Many patients with severe rheumatoid arthritis don't take their expensive medications as prescribed, a new British study finds.

Failure to take the drugs correctly reduces their effectiveness and may lead to a worsening of symptoms, warned researchers from the University of Manchester.

Rheumatoid arthritis develops when your immune system begins to attack itself, and symptoms include inflammation, pain and swelling in the joints and internal organs.

The study included 286 patients who had rheumatoid arthritis for seven years and had been prescribed anti-TNF drugs, which cost about $13,000 to $20,000 a year per patient. Anti-TNF drugs include etanercept (Enbrel), adalimumab (Humira) and golimumab (Simponi).

Twenty-seven percent of the patients said they didn't take the medications as directed at least once over the first six months after being prescribed the drugs, according to the study published recently in the journal Rheumatology.

It's not clear whether the patients' failure to take the drugs as prescribed was deliberate or accidental, and further research is needed to learn more about why this occurs, the researchers said.

"If patients do not take their medication as prescribed it is likely to have a significant effect on whether they respond to therapy and could mean that their condition deteriorates more quickly, affecting their quality of life," study author and rheumatology expert Dr. Kimme Hyrich said in a university news release. "Non-adherence is also a waste of scarce health care resources and something that needs to be addressed."

Anti-TNF drugs have transformed the lives of many patients with rheumatoid arthritis and related disorders, Alan Silman, medical director of Arthritis Research UK, said in the news release.

"This success has been at a considerable cost to the [National Health Service] but there was always the assumption that patients prescribed these drugs will have the necessary regular injections," Silman said.

"The fact that a considerable proportion of patients are missing doses of these very expensive agents is worrying, as clearly their effectiveness would be reduced," he added.

More information

The U.S. National Library of Medicine has more about rheumatoid arthritis.

SOURCE: University of Manchester, news release, Aug. 28, 2014

--


'/>"/>
Copyright©2014 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis
2. Genotyping can predict disease outcomes in rheumatoid arthritis patients
3. Benaroya Research Institute scientists identify drivers of rheumatoid arthritis
4. Molecules involved in rheumatoid arthritis angiogenesis identified
5. Scientists awarded grant to develop diagnostics for cancer, rheumatoid arthritis, colitis
6. Same-day double knee replacement safe for select rheumatoid arthritis patients
7. A New Article Releases 17 Homeopathic Remedies for Rheumatoid Arthritis – Vinamy
8. Bel Marra Health Reports on Recent Research Revealing a Link Between Intestinal Bacteria and Rheumatoid Arthritis
9. Molecule common in some cancers, rheumatoid arthritis leads to potential therapy for both
10. Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline
11. Rheumatoid arthritis and heart disease: Mayo Clinic studies shed light on dangerous connection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Many Rheumatoid Arthritis Patients May Skip Meds: Study 
(Date:2/5/2016)... NY & Salt Lake City, UT (PRWEB) , ... February 05, ... ... Founder of Activz Whole-Food Nutrition , announced that the much-anticipated feature with author ... the New Really Cool Humans Amateur TV Network. , Each week, on his weekly ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held ... Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research ... Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative event ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... addition of micro-needling services in their Napa Valley office. The technique utilizes the ... Surgery Associates, Dr. Canales and Dr. Furnas, are part of only a select ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... H. Van Allen have signed a joint enrollment and degree completion agreement. ... toward associate and baccalaureate degrees at FHU|Dickson. , The agreement allows students ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to once again host, Swirl, A Wine Tasting Event at the La Gorce ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Wegener Polyangiitis ... Global Markets Direct,s, ,Wegener Polyangiitis - Pipeline Review, ... Polyangiitis,s therapeutic pipeline. This report provides comprehensive ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ...
(Date:2/4/2016)... 4, 2016 Frontier Pharma: Chronic Obstructive ... Innovation Chronic Obstructive Pulmonary Disease ... inflammation of the airways and lungs. Persistent breathing ... the disease one of the leading causes of ... the world. COPD is linked to cumulative exposure ...
(Date:2/4/2016)... SILVER SPRING, Md. , Feb. 4, 2016 ... Robert Califf , the FDA,s Deputy Commissioner for Medical Products ... far-reaching action plan to reassess the agency,s approach to opioid ... the epidemic, while still providing patients in pain access to ... The FDA will: , Re-examine the risk-benefit ...
Breaking Medicine Technology: